The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

A 2024 federal rule that shielded reproductive health information from disclosure to law enforcement when care was legally obtained, such as in another state with abortion access, was struck down by a ...